logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
A

Alfred L. Garfall

Abramson Cancer Center
H指数:41
被引数:1.1万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Revised Recommendations for Restarting Teclistamab Following Dose Delays: Insights from the MajesTEC-1 Study on Clinical Safety, and from Simulated Pharmacokinetics and Cytokine Dynamics

关于在剂量延迟后重新开始Tecclistamab的修订建议：来自MajesTEC-1研究的临床安全性见解，以及来自模拟药代动力学和细胞因子动力学的研究

Targeted Oncology
IF4
2026-03-260
OAAI
Natalia A. Quijano Cardé; Jin Niu; Yue Guo; Jia Zhou; Xiao Qiu; Yaming Su; Carlos Pérez-Ruixo; Deeksha Vishwamitra; Caroline Hodin; Tara Stephenson; Athena Zuppa; Katherine Chastain; Rachel Kobos; Mahesh N. Samtani; Weirong Wang; Nahor Haddish-Berhane; Niels W. C. J. Van de Donk; Alfred L. Garfall; Jeffrey V. Matous
Predictive biomarkers of response to chimeric antigen receptor (CAR) T-cell therapy for pan-haematologic cancer

泛血液学癌症对嵌合抗原受体 (CAR) T细胞治疗反应的预测生物标志物

Nature Biomedical Engineering
IF26.6
2026-03-090
PRE
Gregory M. Chen; Ankita Jain; David T. Gering; Javier Satulovsky; Sarbani Datta; Peng Lai; Jayashree Karar; Vanessa E. Gonzalez; Kathleen Alexander; Anne Chew; Julie K. Jadlowsky; Marco Ruella; Luca Paruzzo; Kevin R. Amses; Andrew J. Rech; Edward A. Stadtmauer; Noelle V. Frey; Elizabeth O. Hexner; David L. Porter; Adam D. Cohen; Saar I. Gill; Alfred L. Garfall; Stephen J. Schuster; Kelvin C. Mo; Samantha I. Liang; Marko Spasic; Bruce L. Levine; Don L. Siegel; Angel Ramírez-Fernández; Christopher R. Cabanski; EnJun Yang; Crystal L. Mackall; Frederic D. Bushman; Zinaida Good; E. John Wherry; Carl H. June; Joseph A. Fraietta
CD4+ T cells mediate CAR-T cell-associated immune-related adverse events after BCMA CAR-T cell therapy

CD4 T细胞介导BCMA car-t细胞治疗后car-t细胞相关的免疫相关不良事件

Nature Medicine
IF50
2026-01-150
PRE
Matthew Ho; Luca Paruzzo; Julia Han Noll; Federico Stella; Pooja Devi; Sonia Ndeupen; Yael A. Day; Gregory M. Chen; Ivan J. Cohen; Angel Ramirez-Fernandez; Adam Waxman; Shivani Kapur; Fang Chen; Rong Xu; Andrew Huff; Danuta Jarocha; Vrutti Patel; Audrey C. Bochi-Layec; Ranjani Ramasubramanian; Shan Liu; Riemke Bouvier; Vitor B. de Souza; Heta Patel; Ziyu Li; Alberto Carturan; Peter Michener; Caitlin R. Hopkins; Owen Koucky; Janna Minehart; Alex Dimitri; Neel R. Nabar; Zainul S. Hasanali; Bryan T. Ciccarelli; Putzer Hung; Erik Williams; Robert Bartoszek; Maya Lavorando; Suyash Mohan; Vanessa E. Gonzalez; Patrizia Porazzi; Vijay G. Bhoj; Sokratis A. Apostolidis; Dan T. Vogl; David L. Porter; John Scholler; Caroline Diorio; Aoife M. Roche; John K. Everett; Frederic D. Bushman; Katherine L. Nathanson; Edward A. Stadtmauer; Sandra P. Susanibar-Adaniya; Alfred L. Garfall; Marco Ruella; Adam D. Cohen; Joseph A. Fraietta
Efficacy and safety of teclistamab in triple-class exposed relapsed/refractory multiple myeloma: Pooled findings from three clinical cohorts and a retrospective cohort

三线治疗后复发/难治性多发性骨髓瘤中特克替单抗的疗效和安全性：三项临床队列和一项回顾性队列的合并分析结果

Cancer
IF5.1
2026-01-011
OAAI
Martin, Thomas G.; Mateos, Maria-Victoria; Yi, Jun Ho; van de Donk, Niels W. C. J.; Cai, Zhen; Fu, Weijun; Garfall, Alfred L.; Iida, Shinsuke; Jung, Sung-Hoon; Kuroda, Yoshiaki; Niu, Ting; Nooka, Ajay K.; Min, Chang-Ki; Sidana, Surbhi; Chastain, Katherine; Doyle, Margaret; Nishikawa, Kazuko; Wang, Xiaohong; Song, Yang; Yamazaki, Hiroshi; Izumi, Yusuke; Zhuo, Jianmin; Zhu, Angeline; Yoon, Dok Hyun; Du, Juan; Ishida, Tadao
The impact of extramedullary and paraskeletal plasmacytomas on treatment outcomes in multiple myeloma treated with teclistamab: U.S. Myeloma Immunotherapy Consortium real-world experience

外周髓外和骨旁浆细胞瘤对使用teclistamab治疗的多发性骨髓瘤患者治疗结局的影响：美国骨髓瘤免疫治疗联盟真实世界经验

Blood Cancer Journal
IF11.6
2025-11-280
OAAI
Aimaz Afrough; Danai Dima; Beatrice Razzo; Utkarsh Goel; Aishwarya Sannareddy; Oren Pasvolsky; Mariola A. Vazquez-Martinez; Christopher J. Ferreri; Rahul Banerjee; Jack Khouri; James A. Davis; Mahmoud R. Gaballa; Alex Lieberman-Cribbin; Masooma S. Rana; Kelley Julian; Faiz Anwer; Leyla Shune; Shaun DeJarnette; Ariel F. Grajales-Cruz; Evguenia Ouchveridze; Gabriel De Avila; Sandra P. Susanibar-Adaniya; Andrew J. Portuguese; Daniel Schrum; Erin Eberwein; Hitomi Hosoya; Lekha Mikkilineni; Gurbakhash Kaur; Joseph P. McGuirk; Adriana Rossi; Megan M. Herr; Omar Castaneda; Frederick L. Locke; Shahzad Raza; Yi Lin; Shebli Atrash; Douglas W. Sborov; Peter M. Voorhees; Shambavi Richard; Alfred L. Garfall; Surbhi Sidana; Krina K. Patel; Doris K. Hansen; Andrew J. Cowan; Larry D. Anderson; Hans C. Lee
Outcomes of relapse after teclistamab therapy in multiple myeloma

接受特昔利珠单抗治疗后多发性骨髓瘤复发的结局

Blood Cancer Journal
IF11.6
2025-11-050
OAAI
Kyle L. Yu; Matthew Ho; Luca Paruzzo; Federico Stella; Heta Patel; Zainul S. Hasanali; Shivani Kapur; Adam J. Waxman; Dan T. Vogl; Edward A. Stadtmauer; Joseph A. Fraietta; Marco Ruella; Adam D. Cohen; Alfred L. Garfall; Sandra Susanibar-Adaniya
Predictors of Delayed Responses to Teclistamab in Multiple Myeloma After Initial Non-Response

多发性骨髓瘤患者对特克替玛初始无应答后延迟应答的预测因子

American Journal of Hematology
IF9.9
2025-10-110
OAAI
Rahul Banerjee; Gurbakhash Kaur; Beatrice M. Razzo; Andrew J. Portuguese; Surbhi Sidana; Tiffany Richards; Ariel Grajales-Cruz; Shambavi Richard; Leyla Shune; Jack Khouri; Danai Dima; Hans C. Lee; Krina K. Patel; Oren Pasvolsky; Mariola Vazquez-Martinez; Doris K. Hansen; Aimaz Afrough; James A. Davis; Hamza Hashmi; Shebli Atrash; Christopher J. Ferreri; Kelley L. Julian; Megan M. Herr; Shonali Midha; Patrick Costello; Peter Forsberg; Andre de Menezes Silva Corraes; Yi Lin; Andrew J. Cowan; Larry D. Anderson Jr; Alfred L. Garfall
Outcomes of teclistamab in patients with relapsed/refractory multiple myeloma with prior exposure to BCMA-directed therapy: a multicenter study from the U.S. Multiple Myeloma Immunotherapy Consortium

接受过BCMA靶向疗法的复发/难治性多发性骨髓瘤患者中teclistamab的治疗效果：一项来自美国多发性骨髓瘤免疫治疗联盟的多中心研究

Blood Cancer Journal
IF11.6
2025-06-250
OAAI
Danai Dima; Mariola A. Vazquez-Martinez; James A. Davis; Utkarsh Goel; Aimaz Afrough; Aishwarya Sannareddy; Oren Pasvolsky; Beatrice Razzo; Rahul Banerjee; Jack Khouri; Ariel Grajales-Cruz; Alex Lieberman-Cribbin; Masooma Shifa Rana; Kelley Julian; Shaun DeJarnette; Andrew J. Portuguese; Mahmoud R. Gaballa; Gabriel De Avila; Sandra Susaniba Adaniya; Shahzad Raza; Megan M. Herr; Evguenia Ouchveridze; Tiffany Richards; Hitomi Hosoya; Lekha Mikkilineni; Gurbakhash Kaur; Omar Castaneda Puglianini; Adriana Rossi; Yi Lin; Shebli Atrash; Douglas Sborov; Kenneth H. Shain; Peter M. Voorhees; Shambavi Richard; Alfred L. Garfall; Doris K. Hansen; Surbhi Sidana; Krina K. Patel; Andrew J. Cowan; Larry D. Anderson; Hans C. Lee; Faiz Anwer; Christopher J. Ferreri; Leyla Shune
Outcomes of elderly patients with relapsed refractory multiple myeloma (RRMM) treated with teclistamab: a multicenter study from the US Multiple Myeloma Immunotherapy Consortium

复发难治性多发性骨髓瘤（RRMM）老年患者接受teclistamab治疗后的结局：一项来自美国多发性骨髓瘤免疫治疗联盟的多中心研究

BLOOD CANCER JOURNAL
IF11.6
2025-05-090
OA
Pasvolsky, Oren; Dima, Danai; Feng, Lei; Dong, Wenli; Richards, Tiffany; Davis, James A.; Afrough, Aimaz; Vazquez-Martinez, Mariola; Sannareddy, Aishwarya; Goel, Utkarsh; Banerjee, Rahul; Khouri, Jack; Cervoni, Frances; Gaballa, Mahmoud R.; Lieberman-Cribbin, Alex; Rana, Masooma Shifa; Julian, Kelley; Ferreri, Christopher J.; Shune, Leyla; Dejarnette, Shaun; Bhurtel, Evguenia; Susanibar Adaniya, Sandra; Portuguese, Andrew; Hosoya, Hitomi; Mikkilineni, Lekha; Kaur, Gurbakhash; Rossi, Adriana; Herr, Megan M.; Schrum, Daniel; Lin, Chenyu; Raza, Shahzad; Lin, Yi; Midha, Shonali; Omar, Nadeem; Atarsh, Shebli; McGuirk, Joseph; Sborov, Douglas; Voorhees, Peter; Anwer, Faiz; Alsina, Melissa; Freeman, Ciara; Garfall, Alfred L.; Razzo, Beatrice M.; Sidana, Surbhi; Cowan, Andrew J.; Anderson Jr, Larry D.; Hansen, Doris K.; Richard, Shambavi; Patel, Krina K.; Lee, Hans C.; Grajales-Cruz, Ariel
Expert Perspectives on Current Challenges and Emerging Approaches for Multiple Myeloma: Narrative Review of an Inaugural Bridging the Gaps in Leukemia, Lymphoma, and Multiple Myeloma

多发性骨髓瘤当前挑战与新兴策略的专家观点：白血病、淋巴瘤和多发性骨髓瘤领域“弥合差距”首届叙事综述

clinical lymphoma myeloma leukemia
IF0
2025-03-110
PRE
Ajai Chari; Susan Bal; Sikander Ailawadhi; Amrita Krishnan; Krina K. Patel; Jesus G. Berdeja; Alfred Garfall; Natalie Callander; Rahul Banerjee; Melissa Alsina; Ajay K. Nooka; Binod Dhakal; Cristina Gasparetto; Caitlin Costello
Prolonged Neurologic Symptoms Following Immune Effector Cell-Associated Neurotoxicity Syndrome in Patients With Large B-cell Lymphoma Treated With Chimeric Antigen Receptor-Modified T Cell Therapy

经嵌合抗原受体修饰的T细胞治疗的大b细胞淋巴瘤患者免疫效应细胞相关神经毒性综合征后神经系统症状延长

TRANSPLANTATION AND CELLULAR THERAPY
IF4.4
2025-01-010
PRE
Maillie, Luke; Nasta, Sunita D.; Svoboda, Jakub; Barta, Stefan K.; Chong, Elise A.; Garfall, Alfred L.; Gill, Saar I.; Porter, David L.; Schuster, Stephen J.; Catania, Christopher; Frey, Noelle, V; Landsburg, Daniel J.
Higher Teclistamab Step-up Dosing in Patients with Relapsed or Refractory Multiple Myeloma (RRMM): Results from the Majestec-1 Trial

高剂量Tecelistamab阶梯给药在复发或难治性多发性骨髓瘤（RRMM）患者中的疗效：Majestec-1试验结果

BLOOD
IF23.1
2024-11-050
PRE
Matous, Jeffrey, V; van de Donk, Niels W. C. J.; Oriol, Albert; Garfall, Alfred L.; Rodriguez-Otero, Paula; Chalopin, Thomas; Dachs, Laura Rosinol; Uttervall, Katarina; Mateos, Maria- Victoria; Trancucci, Danielle; Carde, Natalia Quijano; Hodin, Caroline; Stephenson, Tara; Zuppa, Athena; Chastain, Katherine; Karlin, Lionel
Efficacy and Safety of Anti-CDI9 and Anti-BCMA Chimeric Antigen Receptor (CAR) T-Cell Therapies in Patients with Autoimmune Disease and Lymphoma or Myeloma

抗CDI9和抗BCMA嵌合抗原受体（CAR）T细胞疗法在自身免疫性疾病、淋巴瘤或骨髓瘤患者中的疗效与安全性

BLOOD
IF23.1
2024-11-050
PRE
Paruzzo, Luca; Bouvier, Riemke; Ghilardi, Guido; Fardella, Eugenio; Fulmer, Bria; Cohen, Ivan J.; Chong, Elise A.; Svoboda, Jakub; Nasta, Sunita D.; Landsburg, Daniel J.; Patel, Vrutti; Ziyu, Li; Pajarillo, Raymone; Waxman, Adam; Cohen, Adam D.; Vogl, Dan T.; Barta, Stefan K.; Porazzi, Patrizia; Fraietta, Joseph A.; Bhoj, Vijay; Garfall, Alfred L.; Stadtmauer, Edward A.; Schuster, Stephen J.; Carter, Jordan S.; Apostolidis, Sokratis A.; Susanibar-Adaniya, Sandra; Ruella, Marco
Analysis of Repeat Step-up Dosing and Cytokine Release Syndrome Events Following Prolonged Dosing Intervals of Teclistamab in the Phase 1/2 Majestec-1 Study

分析Majestec-1研究（I/II期）中，延长给药间隔后进行重复逐步加量与细胞因子释放综合征事件的关系

BLOOD
IF23.1
2024-11-050
PRE
van de Donk, Niels W. C. J.; Chari, Ajai; Karlin, Lionel; Krishnan, Amrita Y.; Uttervall, Katarina; Chalopin, Thomas; Dachs, Laura Rosinol; Oriol, Albert; Matous, Jeffrey, V; Bhutani, Manisha; Rodriguez, Cesar; Carde, Natalia Quijano; Guo, Yue; Hodin, Caroline; Uhlar, Clarissa; Stephenson, Tara; Zuppa, Athena; Doyle, Margaret; Chastain, Katherine; Garfall, Alfred

研究方向

暂未获取到该数据
D
Dan T. Vogl
H 指数:50论文数:358被引数:1.7万
A
Adam D. Cohen
H 指数:63论文数:442被引数:1.8万
E
Edward A. Stadtmauer
H 指数:88论文数:628被引数:3.6万
S
Sandra P. Susanibar-Adaniya
H 指数:10论文数:121被引数:1,043
C
Carl H. June
H 指数:177论文数:1,428被引数:14.4万
J
Jakub Svoboda
H 指数:46论文数:428被引数:9,139
M
Marco Ruella
H 指数:48论文数:344被引数:1.3万
S
Sunita D. Nasta
H 指数:40论文数:367被引数:9,932
S
Stephen J. Schuster
H 指数:75论文数:807被引数:3.2万
E
Elise A. Chong
H 指数:29论文数:263被引数:6,234